{"DataElement":{"publicId":"6333879","version":"1","preferredName":"Ovarian Mass Internal Cell Structure Type","preferredDefinition":"The type of internal cellular arrangement within an abnormal growth in the ovary.","longName":"OV_MASS_INT_CELL_STRCT_TP","context":"CIP","contextVersion":"2.31","DataElementConcept":{"publicId":"6333872","version":"1","preferredName":"Ovarian Mass Internal Cell Structure","preferredDefinition":"An abnormal growth in the ovary._Happening or arising or located within some limits, or especially, within some surface._The components of the cell and how they are arranged.","longName":"6315984v1.0:6333870v1.0","context":"CIP","contextVersion":"2.31","ObjectClass":{"publicId":"6315984","version":"1","preferredName":"Ovarian Mass","preferredDefinition":"An abnormal growth in the ovary.","longName":"C3882","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Mass","conceptCode":"C3882","definition":"An abnormal growth in the ovary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D772A52-9642-4CA6-E053-F662850A9EB6","latestVersionIndicator":"Yes","beginDate":"2018-05-30","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-30","modifiedBy":"ONEDATA","dateModified":"2018-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6333870","version":"1","preferredName":"Internal Cell Structure","preferredDefinition":"Happening or arising or located within some limits, or especially, within some surface.:The components of the cell and how they are arranged.","longName":"C25234:C14135","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Internal","conceptCode":"C25234","definition":"Happening or arising or located within some limits, or especially, within some surface.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cell Structure","conceptCode":"C14135","definition":"The components of the cell and how they are arranged.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E685247-7E01-79F9-E053-F662850A4151","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"ONEDATA","dateModified":"2018-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6E685247-7E12-79F9-E053-F662850A4151","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"SOKKERL","dateModified":"2018-11-19","changeDescription":"11/19/18 ls Released per CIP PI review (Justin, Brenda).6/11/18 jk created for CIP TCIA/TCGA OV features project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6333855","version":"1","preferredName":"Cell Structure Type","preferredDefinition":"The components of the cell and how they are arranged._Something distinguishable as an identifiable class based on common qualities.","longName":"6333855v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Mixed","valueDescription":"Mixed Neoplasm","ValueMeaning":{"publicId":"4824500","version":"1","preferredName":"Mixed Neoplasm","longName":"4824500","preferredDefinition":"A tumor composed of at least two distinct cellular populations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Neoplasm","conceptCode":"C6930","definition":"A neoplasm composed of at least two distinct cellular populations.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EE070C-4B42-0882-E050-BB89AD43797F","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E660739-7EC4-4E5D-E053-F662850A4A2E","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"ONEDATA","dateModified":"2018-06-11","deletedIndicator":"No"},{"value":"Predominantly Solid","valueDescription":"Main Solid Neoplasm","ValueMeaning":{"publicId":"6333856","version":"1","preferredName":"Main Solid Neoplasm","longName":"6333856","preferredDefinition":"Most important; principal.: A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Main","conceptCode":"C25562","definition":"Most important; principal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E660739-7ED2-4E5D-E053-F662850A4A2E","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"ONEDATA","dateModified":"2018-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E660739-7EEB-4E5D-E053-F662850A4A2E","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"ONEDATA","dateModified":"2018-06-11","deletedIndicator":"No"},{"value":"Predominantly Cystic","valueDescription":"Main Cystic Neoplasm","ValueMeaning":{"publicId":"6333857","version":"1","preferredName":"Main Cystic Neoplasm","longName":"6333857","preferredDefinition":"Most important; principal.: A benign or malignant neoplasm that contains a single or multiple cystic spaces.  Examples include cystadenoma, mucinous cystadenocarcinoma, and serous cystadenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Main","conceptCode":"C25562","definition":"Most important; principal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cystic Neoplasm","conceptCode":"C6784","definition":"A benign or malignant neoplasm that contains a single or multiple cystic spaces.  Examples include cystadenoma, mucinous cystadenocarcinoma, and serous cystadenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E660739-7EF8-4E5D-E053-F662850A4A2E","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"ONEDATA","dateModified":"2018-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6E660739-7F11-4E5D-E053-F662850A4A2E","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"ONEDATA","dateModified":"2018-06-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6333854","version":"1","preferredName":"Cell Structure Type","preferredDefinition":"The components of the cell and how they are arranged.:Something distinguishable as an identifiable class based on common qualities.","longName":"C14135:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell Structure","conceptCode":"C14135","definition":"The components of the cell and how they are arranged.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E660739-7E92-4E5D-E053-F662850A4A2E","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"ONEDATA","dateModified":"2018-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6E660739-7EA3-4E5D-E053-F662850A4A2E","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"SOKKERL","dateModified":"2018-11-19","changeDescription":"11/19/18 ls Released per CIP PI review (Justin, Brenda).6/11/18 jk created for CIP TCIA Ovarian Feature key study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2180933","version":"1","longName":"FNL Research Activities","context":"CIP","ClassificationSchemeItems":[{"publicId":"6343663","version":"1","longName":"Ovarian Features","context":"CIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Internal architecture","type":"Preferred Question Text","description":"Internal architecture","url":null,"context":"CIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E681C49-3C26-0728-E053-F662850A04A3","latestVersionIndicator":"Yes","beginDate":"2018-06-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-06-11","modifiedBy":"KNABLEJ","dateModified":"2022-02-23","changeDescription":"2/23/22 jk per qtrly review, this CDE was still Draft New,  Changed to Released per 2018 note. 11/19/18 ls Released per CIP PI review (Justin, Brenda).6/11/18 jk created for CIP TCIA/TCGA OV features.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}